We aim to foster a culture of entrepreneurship, innovation and success among engineers in the UK, creating economic growth and societal impact. At the heart of how we do this are the Hub Members, the promising entrepreneurs who we support through our programmes, and our Hub Mentors, the business leaders who volunteer their expertise and time to help the Hub Members succeed.
From manufacturing to medtech, our Hub Membership is made up of some of the UK’s most innovative entrepreneurs. But don’t just take our word for it: read more about our Hub Members to see how they are, without exaggeration, changing the world.
Surgeons need accurate, objective information to support decision making during minimally invasive surgery. They regularly rely on sight for intricate processes such as placing stents - small metallic tubes - in blood vessels in brain aneurysm patients. Better information could improve patient outcomes and save millions of pounds from being spent on corrective surgeries.
After her PhD at Oxford in Biomedical Engineering, Katerina Spranger has founded Oxford Heartbeat – a start-up company that has developed a medical device that accurately simulates the behaviour of medical devices inside patient’s brain during surgery.
Engineered to achieve extremely high levels of accuracy, the device improves surgeons’ ability to choose the correct stent for every individual patient. This aims to reduce surgery times, improve patient outcomes, decrease the likelihood of repeat surgeries, and save costs for hospitals and wider society.
The technology has been designed for easy and intuitive use by surgeons. By combining accessibility with precision, this virtual platform has the potential to become an essential tool for minimally invasive brain surgery. The start-up’s plans include exploring the use of its technology to optimise other types of surgery in the future.
Katerina was awarded the 2017 Enterprise Fellowship to continue developing this technology and her start-up, Oxford Heartbeat.
When Disabled Student Allowance funding for transcription services and note-takers was abolished in 2016, universities scrambled to find ways of supporting disabled students. Existing transcription services were prohibitively expensive and disabled students were at risk of missing out on hours of lectures each week.
Dr Yunjia Li and Professor Mike Wald founded Synote to address the need for accessible lecture videos. Synote is designed to deliver videos that are less costly and produced quicker than traditional methods. The system automatically generates an interactive transcript and captions from a video or audio copy of a lecture, and can integrate with university lecture-capture systems.
Synote can process the many tens of thousands of lectures given at universities each year, and users can quickly search through their transcripts for specific topics. The system even creates screenshots for each part of the lecture which can be printed with the transcript. Synote can also be used to automatically translate lecture transcripts into other languages, which can open up university education to a much broader base of international students. A unique ‘feedback loop’ enables students to correct speech recognition transcription errors to continually improve the transcript’s accuracy as the system ‘learns’ how to match new words with sounds.
Southampton University has invested significantly in Synote and other leading universities have expressed great interest. The ability to improve the learning experience of all students and particularly students with difficulties hearing or understanding lecturers, taking notes or attending lectures is of great value and significance to these institutions.
Although Synote was originally developed for universities, it can reduce the cost of captions and transcriptions in any business where video or audio recordings are used.
A child dies of malaria every two minutes, often because they arrive at hospital too late to be saved. The disease is one of the world’s most deadly, with approximately 207 million infections and more than 600,000 deaths each year. Drug resistance is spreading globally and many strains of the disease are untreatable.
George developed the MediSieve system to tackle this terrible situation. MediSieve uses haemofilter technology which ‘sieves’ the blood rapidly and safely reduces malarial parasites from a patient's system. This novel technology requires no drugs or chemicals and can be used to treat any malaria patient, including drug-resistant and other untreatable cases, keeping patients alive and symptom-free indefinitely.
Used either in isolation or as a stand-alone treatment, the haemofilter removes malaria infected cells directly from the bloodstream in a dialysis-like process.
In severe cases, MediSieve could reduce mortality and recovery times; in non-severe cases, patients could recover in hours rather than days as the efficacy of drugs is increased and their side-effects eliminated.
Following extensive trials, MediSieve products will be commercially available in the next couple of years.
Christine Boyle was working as the managing director of her family roofing business when she realised that there was huge potential for the collection of solar heat energy on the large commercial flat roofs that her company constructed. Solar thermal is a renewable energy that is 70% efficient, produces the lowest carbon emissions, and is easily generated on site, but had not been widely used because of its expense, weight and inflexibility with existing architecture.
Christine set up Senergy Innovations to create the next generation of solar thermal panels. She worked with Queen’s University Belfast and the University of Ulster to produce the product, ensuring that the renewable energy panels addressed the problems that previous solar thermal panels faced as well as making panels that appealed to consumers and architects.
Senergy Innovations’ solar thermal panel is made from 100% polymer plastic, making it 50% cheaper to manufacture and install than existing products. The panels incorporate carbon nanotube materials that enhance the thermal performance and mechanical strength, which ensures that they are durable. The module panels are lightweight, and allow integrations with both existing and new buildings, so that renewable thermal energy can be easily generated on site.
Senergy’s solar thermal panels are affordable, durable and easy to integrate, creating a renewable energy solution that is competitive with gas and oil.
A lack of smart energy storage options is linked to poor energy distribution in developing countries and inefficient energy management in developed ones.
Dr Enass Abo-Hamed, CEO and Co-Founder of H2GO Power, has engineered new hydrogen-based energy storage units that use patented catalyst that allow energy to be released on demand.
This clean, low-cost energy storage solution has the capacity to store five to ten times as much energy as their battery equivalents. It could impact energy storage at every scale, from the provision of low-weight energy for drones to large-scale energy storage for national grids.
As an innovator with a strong drive to generate social impact, Enass Abo-Hamed aims to harness the technology’s abilities to utilise excess renewables, and facilitate reliable distribution of power in countries where energy supply is intermittent.
Initiatives are underway to penetrate the fast-growing, green energy market in remote islands, where H2GO Power’s Hydrogen based fuel units would offer a clean, low-cost solution for round-the-clock power.
There is also significant industrial interest from companies keen to explore other ways this disruptive technology can support smarter energy management.
Enass was awarded the 2017 Enterprise Hub Fellowship to help grow and develop her start-up, H2GO Power.
There are more than 100,000 strokes in the UK each year. Almost two-thirds of stroke survivors leave hospital with a disability and in need of rehabilitation, with arms and hands most commonly affected.
Through his digital health startup Neurofenix, Guillem Singla Buxarrais is seeking to increase the accessibility and effectiveness of post-stroke rehabilitation with the NeuroBall, a novel and cost-effective medical device making bold changes to stroke rehabilitation.
Physiotherapy exercises can be repetitive and boring, whereas the Neuroball encourages users to exercise the whole arm, from shoulder to fingers, through a set of entertaining games, keeping the user engaged in their therapy.
Engineered with stroke survivors and physiotherapists from inception, the mobile application and handheld controller is a user-friendly device that helps people to regain function in an enjoyable way, as verified in user testing.
Guillem’s experience of volunteering in stroke rehabilitation motivated him to ensure that stroke survivors and physiotherapists were involved with the engineering of the device from inception. The mobile application and handheld controller is user-friendly and helps people to regain function in an enjoyable way, as verified in user testing.
The Neuroball has been engineered to sensitively monitor recovery. It shows stroke survivors their progress, and they can share results with a supportive online community, helping them to feel re-connected with family, friends and other survivors.
Guillem was awarded a 2017 Enterprise Fellowship supported by the Royal Commission for the Exhibition of 1851 to continue developing this technology and the Neurofenix team has grown rapidly as a result. It is also supported by the Nominet Trust and Entrepreneur First.
"The Enterprise Fellowship had a profound impact on Neurofenix’s progress and reducing our time to market. Our mentor and the Enterprise team provided invaluable support throughout."
Oliver has spent over five years as part of a team developing clinical probes that could revolutionise cancer screening. They are committed to enabling on-the-spot cancer diagnosis with minimal discomfort for patients - and without an anxious wait for results.
The group has developed a proprietary method of using small probes using fibre optics to direct laser light onto cells. They then analyse the interaction of this light with the molecules inside. This provides a molecular ‘fingerprint’ to identify different types of cells and any cancerous changes within them.
Using this technique can yield almost instantaneous results and is both faster and more objective than current testing. Traditional testing involves sending tissue that has been surgically removed to a lab to be analysed by a pathologist, a process that is traumatic for the patient and costly for the system.
The new process has been demonstrated to be at least as accurate as conventional gold standard pathology. However it doesn’t require the removal of tissue and allows for the immediate intervention and ongoing monitoring by clinicians.
In future, the technology is seen to have many other clinical applications as well as this humane testing process.
The technique has already undergone extensive tests on human tissue at Gloucestershire Hospitals NHS Foundation Trust, with one of the probes set to begin clinical trials within 18 months.
Since Bethan was 15 she has been fascinated by DNA, "I mean what could be cooler than understanding the code of life?" She wondered. Following her passion took her to University College London and gave her access to machines that could sample DNA - hugely expensive machines that only a few people could ever dream of using.
A college competition entered with friends started her on the road to creating the Bento Lab - a personal DNA lab that costs as much as a laptop and is not much bigger or heavier.
Now field workers can take their own kit with them rather than having to go back to their labs and anyone - not just professionals - with a passion for biology can sample their own genes or see what is in their beer. Or for the very brave, their burgers. Who knows what future Bethans armed with the Bento Lab will discover?
Her company, Bento Bioworks, is making learning and working with molecular biology orders of magnitude more accessible. The toolkit weighs only 3kg, fits on an A4 footprint, and contains all the equipment required to carry out basic research in molecular biology. This has widespread implications for science and engineering education as bento•lab users will be able to engage hands-on with genetic engineering and could potentially contribute to large-scale research projects. They are already taking orders after a successful Kickstarter campaign.
You can watch a video about bento•lab here.
“One of the challenges we all face is thinking that there’s a perfect time to start your own business. The harsh reality is that this mythical moment never arrives. There will always be challenges and excuses to delay making that decision, but at some point you need to get past those mental roadblocks and take the plunge."
in every 300 people worldwide is classified as legally blind. Of these, most (up to 90%) have some remaining sight called residual
vision. This can be limited to an awareness of colour, light, shapes
and motion. Stephen and his team have developed a non-invasive visual
display that can be worn like glasses to enhance the usefulness of
The glasses work by detecting the three dimensional structure of nearby objects and preferentially highlighting the nearest and most important objects, such as people, faces and obstacles.
Traditional assistive technologies for the visually impaired usually involve touch or sound-based devices. Although useful, these older solutions are hard to learn and provide a fairly limited increase in quality of life and independence.
Stephen's company Oxsight (a spin-out of the University of Oxford) is currently refining the prototype into a new lightweight pair of glasses, and a market-ready device is expected soon. It will initially be sold online, and potentially made available on the high street in the future.
What makes us different is the Academy’s Fellows and our wider Mentor network – an unrivalled community of the UK’s most successful industry leaders, technology experts and entrepreneurs. Find out more about our Mentors and their areas of expertise.
David Gammon founded Rockspring in 2002 after 17 years of investment banking experience.
Rockspring provides advice and capital to disruptive technology companies from seed through scale up. His family are the benefactors of the JC Gammon Launchpad Award run by the Enterprise Hub.
David is a non-executive director at Raspberry Pi Trading Limited, Accesso Technology Group plc and Frontier Developments plc.
Suranga has long experience as an engineer and entrepreneur. He founded Blinkx - an intelligent search engine for video and audio content - in 2004. He led Blinkx as CEO for eight years as well as taking it public in 2007. He is widely regarded as an expert on the convergence of the web, television and online advertising.
Before his work with Blinkx, Suranga was US Chief Technology Officer of Autonomy where he was mentored by Mike Lynch and led the effort to enable Autonomy’s software to work in highly distributed environments. Suranga joined Balderton as a General Partner in 2014.
An accomplished speaker and commentator on the overlap between technology and media, Suranga has been elected by the World Economic Forum as one of its Young Global Leaders. He was also included in the Top 10 leaders in Science and Innovation by The Observer’s Future 500 list, and was a recipient of the Royal Academy of Engineering’s Silver Medal in 2012. Suranga was elected a Fellow of the Royal Academy of Engineering (FREng) in 2012.
“The real high-growth value companies are currently all in the tech space. In order for these businesses to reach their potential, it’s vital that they can benefit from the guidance of those with experience.”
Anne is a prominent venture capitalist and European technology investor who has been Chief Executive of Amadeus Capital Partners from 1997. As a co-founder in the organisation, Anne’s role combines her experience as a scientist, operating manager and venture capitalist.
Anne began her career in manufacturing with Cummins Engine Company before moving into investment as a business angel. She was also Chief Operating Officer of Virtuality Group, which had been one of her investee companies.
Anne has held a number of high profile advisory positions, having served as Chairman of the British Venture Capital Association in 2004, and as a non-executive director of the UK Technology Strategy Board from 2005-2012. In 2008 Anne led the establishment of the Glover advisory committee for the Chancellor of the Exchequer, reporting on government procurement from SMEs. She is also a member of the European Research and Innovation Advisory Board. Anne was awarded a CBE for services to business in 2006 and was elected an Honourary Fellow of the Royal Academy of Engineering in 2008.
“There is a long-standing need for science to engage more proactively with policy-makers and business. The Enterprise Hub is playing a big part in addressing this, by bridging the gap between outstanding academic talent and influential figures in the industry to ensure the UK’s ongoing international success in science and technology.”
Chair of the Enterprise Committee and a long-standing Academy Fellow, Ian has played a prominent role in establishing the Enterprise Hub. His track record of helping businesses in the engineering and life science sectors transform their approach and improve their vision, ambition, business models and enterprise value is an invaluable resource.
Ian is currently Managing Director of contract R&D company Arcinova and is also the Managing Partner at investment and advisory firm Shott Trinova LLP. Prior to his specialist investment work at Shott Trinova, Ian was the founder and CEO of Excelsyn, which was sold to an American multinational in 2010. Earlier in his illustrious career he held numerous senior executive positions at multinational life science companies across the globe.
Ian has a wealth of experience with major industry bodies. He is currently the Chair of the UK government’s Leadership Forum for Industrial Biotechnology and a Governing Board Member of Innovate UK. Ian is also Visiting Professor at Oxford, Nottingham and Newcastle Universities.
“Apart from a deep-seated passion to change the entrepreneurial landscape in the UK and rediscover our legacy from the industrial revolution, I am highly excited by the prospect of engaging with new young talent and using my experience to accelerate and amplify their success. I’ve been involved in mentoring for over a decade but believe the Hub offers a very special opportunity to work with the brightest and best”.
Dick Whittington is a serial entrepreneur, business mentor and investor, focusing on the software industry and digital marketplaces, with over thirty years of experience in business. His experience has included co-founding a successful international software business recognised in UK through three Queen's Awards covering both Innovation and International Trade.
In 2012 he was elected Fellow of the Royal Academy of Engineering where he plays an active role including as a mentor for early-stage technology startups and spinouts through its highly successful Enterprise Hub. From 2015 Dick has been Visiting and Honorary Professor of Business Innovation at the University of York, where he has developed and delivered a respected course in Digital Innovation and Entrepreneurship for students and staff. He is also an active mentor and angel investor within several London and regional technology accelerator programmes.
Prior to pursuing business interests, Dick lectured in Computer Science at the University of York. He managed a successful research team and published a number of research papers and books, including Database Systems Engineering (1987), which became a standard text within many universities. He also contributed to several significant texts including The Software Life Cycle (1990) and the Software Engineers' Reference Book (1991).
"The concept of the Enterprise Hub resonated with me as a solid, practical initiative to benefit UK engineering through engaging the Academy’s extraordinary network of talent. The role of the Hub in launching and scaling such businesses is of enormous value to the UK economy and the engineering profession.”
Mike is a leading Silicon Fen-based entrepreneur. He is best known as a co-founder of enterprise software company Autonomy and founder of Invoke Capital, which invests in promising British technology businesses.
A celebrated technologist with a proven track record of identifying and monetising fundamental technologies, Mike has been recognised as one Britain’s most successful entrepreneurs in the industry. The Times has referred to Mike as “the closest thing Britain has to its own Bill Gates”.
Mike studied Information Sciences, received a PhD and held a research fellowship in adaptive pattern recognition at Cambridge University. After co-founding Autonomy he served as CEO for over fifteen years, during which time it became one of the UK’s most successful technology companies on the FTSE100. His latest venture Invoke Capital has raised over $1billion since its launch in 2012 and made its first investment in the cyber-security firm Darktrace in 2013 ,now valued at $800m, other investment areas include machine learning to automate legal functions, augmented reality and genomics.
Mike has received a number of prestigious honours throughout his career. He was named Entrepreneur of the Year in 1999 by the Confederation of British Industry; presented with an award for Autonomy as a technology pioneer by The World Economic Forum in 2000, and awarded an OBE in 2006 for Services to Enterprise. He has been a Fellow of the Royal Academy of Engineering from 2008.
“It’s vital that we encourage and support emerging UK technology businesses, and mentoring programmes are a great way of guiding those with fundamentally clever ideas to fulfil their potential. I’m proud to be a part of the Enterprise Hub, which is helping to ensure the next generation of talent keeps Britain at the forefront of science and innovation.”
Phil is an active Cambridge-based angel investor where he chairs, coaches, invests in and helps communications, software and device companies. He is a frequent speaker on a broad range of entrepreneurial topics and an advisor to universities on the commercialisation of their IP.
In 1999 Phil co-founded the spin-out Cambridge Silicon Radio (CSR) and as managing director, helped to grow CSR plc from a startup of nine people into a highly successful FTSE 250 listed fabless semiconductor company. In 2003, CSR plc had become the largest global market supplier of Bluetooth chips. By 2015, they had shipped three billion chips, employed more than 2,000 people in 23 locations and was acquired by US-based Qualcomm for $2.5 billion.
Phil has been a research fellow at AERE, a chief research engineer at Standard Telecommunication Laboratories, UK Alvey & CEC ESPRIT project manager and a telecoms practice manager at Arthur D Little’s Cambridge Consultants, from which he spun-out CSR plc.
Phil was a recipient of the MacRobert Award in 2005 along with CSR colleagues, for the world's first high-volume single chip Bluetooth device. He was elected as a Royal Academy of Engineering Fellow in 2017 and holds an honorary doctorate from the University of Essex.
“I believe that the commercialisation of IP and the engineering of high-volume products is integral to a vibrant and healthy society. The Enterprise Hub has created an effective mechanism for enabling Fellows to become coaches and mentors to the next generation of engineering entrepreneurs and I am honoured to be in a position to help contribute to its success.”
Formerly the UK Innovation Director for Atkins, Elspeth is the CEO and Founder of IAND, a digital platform that helps major enterprises manage multiple suppliers.
Initially graduating as a chemist, Elspeth later turned her hand to transport and urban design, demonstrating business and technical leadership on over 100 transport planning projects both nationally and around the world.
Elspeth chairs the Enterprise Hub’s Innovators Network and is a judge for the Hub’s Launchpad Competition. She is also a member of the Royal Academy of Engineering’s Diversity and Inclusion Committee.
In 2017, Elspeth was awarded a Member of the Order of the British Empire (MBE) for her services to Engineering and Enterprise.
“I believe that collaboration within our industry is the key to driving innovation faster. I am so proud to be involved with the Enterprise Hub, as a Mentor, and as Chair of the Innovators Network and to support young entrepreneurs as a Judge on Launchpad competition.
It is rare to find a place which brings together startups and established companies to exchange ideas and learn from each other. We have a shared goal which is to fast track the growth of engineering enterprises in the UK. The Enterprise Hub has helped me grow my business and it is helping young engineers build the businesses of the future.”
Nigel’s career has involved working in the UK and the Netherlands for Unilever and Wellcome Research. While abroad, he built and operated the first large-scale Dutch facility for the manufacture of the genetically engineered protein alpha-galactosidase. Later, he led the process design for Wellcome’s WelGen interferon manufacturing plant in the USA.
Nigel has served as a co-founding non-executive director for two manufacturing SMEs, Cobra Biomanufacturing Plc (which was listed on AIM) and Angel Technology Ltd. The latter was awarded the Queen’s Award for Innovation in 2006 and the International Sial d’Or prize for the most innovative new UK nutritional product at the Paris International Food Conference 2004. Currently he is Head of the Department of Chemical Engineering and Biotechnology at Cambridge University.
Nigel was elected a Fellow of the Royal Academy of Engineering (FREng) in 2004.
“My relevant technical and personal experience was well-matched to Janice’s needs and I am pleased to be involved in such a positive initiative.”